President Donald Trump pledged to put an "extremely big dent" in the scourge of drug addiction in America as he signed legislation intended to help tackle the opioid crisis, the deadliest epidemic of overdoses in the country's history.
The CMS hopes to reduce the number of babies born addicted to opioids by launching a new model to treat their mothers.
The Kentucky Hospital Association launched a program allowing hospitals to share patient information so they can better coordinate care for babies born with opioid withdrawal symptoms.
The stigma associated with mental health issues and substance abuse continues to plague the delivery system. For Dr. Stephen Odom, addressing the underlying causes of abuse and mental health is at the core of the mission at New Vista Behavioral Health.
Health insurers in Pennsylvania pledged to remove advanced approval requirements for prescribing medication-assisted treatment for substance use disorder. Advocates expect the move could expand access to thousands throughout the state.
Blue Cross and Blue Shield of Massachusetts is testing out giving large employers opioid-overdose reversal kits and teaching employees how to use them, in hopes of preventing overdose deaths in both public spaces and work environments.
California Gov. Jerry Brown rejected legislation that would have allowed San Francisco to open what could be the nation's first supervised drug injection site. He questioned whether the plan would reduce drug addiction.
The Connecticut Insurance Department will hear pros and cons about CVS Health's proposed acquisition of Aetna.
Congress wraps up work on its opioids legislation, touted as a key campaign-issue healthcare accomplishment ahead of November's midterm elections.
Congress finalized its deal on opioids legislation, including one long-shot measure to free up Medicaid funds for inpatient addiction treatment.
Instagram has begun using some drug-related hashtags, such as “opioid” and “uppers,” to steer users of the app to information about opioid treatment and recovery.
Addiction medicine experts have raised concerns that the Senate opioid bill passed this week is another missed opportunity to make the most impact toward combating the crisis.